New Age Alpha Advisors LLC Buys 18,239 Shares of The Allstate Corporation (NYSE:ALL)

New Age Alpha Advisors LLC boosted its stake in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 60,796.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,269 shares of the insurance provider's stock after purchasing an additional 18,239 shares during the quarter. New Age Alpha Advisors LLC's holdings in Allstate were worth $3,783,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Rehmann Capital Advisory Group lifted its holdings in shares of Allstate by 3.2% during the first quarter. Rehmann Capital Advisory Group now owns 1,630 shares of the insurance provider's stock worth $338,000 after buying an additional 51 shares during the last quarter. Vantage Point Financial LLC raised its stake in shares of Allstate by 3.6% in the first quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider's stock valued at $310,000 after purchasing an additional 52 shares in the last quarter. Confluence Wealth Services Inc. raised its stake in shares of Allstate by 0.7% in the first quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider's stock valued at $1,558,000 after purchasing an additional 54 shares in the last quarter. Achmea Investment Management B.V. raised its stake in shares of Allstate by 0.3% in the first quarter. Achmea Investment Management B.V. now owns 20,586 shares of the insurance provider's stock valued at $4,262,000 after purchasing an additional 57 shares in the last quarter. Finally, Avidian Wealth Enterprises LLC raised its stake in shares of Allstate by 1.7% in the first quarter. Avidian Wealth Enterprises LLC now owns 3,552 shares of the insurance provider's stock valued at $735,000 after purchasing an additional 59 shares in the last quarter. Institutional investors own 76.47% of the company's stock.

Allstate Price Performance

Shares of ALL stock opened at $205.51 on Wednesday. The stock's fifty day moving average is $198.32 and its 200-day moving average is $197.46. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The stock has a market capitalization of $54.15 billion, a PE ratio of 9.66, a PEG ratio of 0.87 and a beta of 0.35. The Allstate Corporation has a 52 week low of $169.20 and a 52 week high of $213.18.

Allstate (NYSE:ALL - Get Free Report) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, topping the consensus estimate of $3.20 by $2.74. The company had revenue of $15.05 billion for the quarter, compared to analysts' expectations of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%. The business's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.61 earnings per share. Equities research analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be issued a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Friday, August 29th. Allstate's dividend payout ratio is presently 18.81%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ALL shares. Raymond James Financial restated a "strong-buy" rating and issued a $260.00 target price (up from $250.00) on shares of Allstate in a research note on Monday. William Blair started coverage on Allstate in a research note on Friday, June 6th. They issued a "sector outperform" rating for the company. Barclays restated an "underweight" rating and issued a $198.00 target price (up from $188.00) on shares of Allstate in a research note on Thursday, July 31st. UBS Group upped their target price on Allstate from $230.00 to $235.00 and gave the company a "buy" rating in a research note on Wednesday, July 9th. Finally, Morgan Stanley upped their target price on Allstate from $235.00 to $245.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. One analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Allstate currently has a consensus rating of "Moderate Buy" and an average price target of $229.40.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.